ENB Therapeutics
  • Home
  • About
  • Pipeline
  • News/Blog
  • Contact Us
Select Page

Start up announcement

by admin | Jun 9, 2015 | Uncategorized

Welcome to ENB Therapeutics. We believe that there are serious deficits in current melanoma therapies. It is our goal to offer better and more cost effective solutions for a devastating disease.

Recent Posts

  • Early efficacy signals in ovarian cancer patients in ongoing Ph1 trial: Poster reporting findings presented at SITC 2020 Annual Meeting
  • ENB Therapeutics Announces Successful Completion of the First Dosing Cohort in Phase 1 Clinical Trial of ENB-003 in Combination with Pembrolizumab
  • IND approval received for lead product ENB-003
  • ENB Therapeutics Announces Clinical Trial Collaboration with Merck to Evaluate ENB-003 in combination with KEYTRUDA® (pembrolizumab) for Advanced Solid Tumors
  • ENB Therapeutics Closes Series A Round of Funding

Recent Comments

  • Mr WordPress on Start up announcement

Archives

  • November 2020
  • February 2019
  • September 2018
  • April 2016
  • January 2016
  • June 2015

Categories

  • Press Releases
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Explore

  • Home
  • About
  • Pipeline
  • News/Blog
  • Contact Us

Recent Posts

Click Here

Contact Us

ENB Therapeutics
Alexandria Center For Life Sciences,
Launch Labs
430 E 29th Street, 14th Floor
New York, NY 10016
(212) 792-2317
info@enbpharma.com

Copyright © 2019 ENB Therapeutics. All rights reserved.